These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 973966)

  • 21. Factors influencing antipyrine elimination.
    Stevenson IH
    Br J Clin Pharmacol; 1977 Jun; 4(3):261-5. PubMed ID: 332216
    [No Abstract]   [Full Text] [Related]  

  • 22. Antipyrine metabolism in patients with diabetes mellitus.
    Murali KV; Adithan C; Shashindran CH; Gambhir SS; Chandrasekar S
    Clin Exp Pharmacol Physiol; 1983; 10(1):7-13. PubMed ID: 6839551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An attempt at assessment of biotransformation activity in calves' liver on the basis of the rate of antipyrine elimination from saliva].
    Janus K; Baranow-Baranowski S; Jakubowska D
    Pol Arch Weter; 1991; 31(3-4):65-71. PubMed ID: 1842615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced drug metabolism in cigarette smokers.
    Hart P; Farrell GC; Cooksley WG; Powell LW
    Br Med J; 1976 Jul; 2(6028):147-9. PubMed ID: 1276835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man.
    Bax ND; Jones RW; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):593-6. PubMed ID: 4005101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B vaccine and antipyrine clearance.
    Bachmann K; Schwartz J; Jauregui L; Forney R
    J Med; 1985; 16(4):453-9. PubMed ID: 2937866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipyrine clearance and metabolism in patients with psoriasis.
    Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K
    Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine.
    Teunissen MW; Meerburg-van der Torren JE; Vermeulen NP; Breimer DD
    J Chromatogr; 1983 Dec; 278(2):367-78. PubMed ID: 6668316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipyrine clearance in children from single saliva samples.
    Loft S; Haxholdt O; Døssing M
    Br J Clin Pharmacol; 1985 May; 19(5):698-700. PubMed ID: 4005107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monthly variations in the clearance of antipyrine in the rat.
    Bélanger PM; Doré F; Labrecque G
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):53-65. PubMed ID: 6505390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipyrene clearance in Indian villagers.
    Desai NK; Sheth UK; Mucklow JC; Fraser HS; Bulpitt CJ; Jones SW; Dollery CT
    Br J Clin Pharmacol; 1980 Apr; 9(4):387-94. PubMed ID: 7378255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary antipyrine half-life during injectable progestagen contraception.
    Joshi JV; Gupta KC; Hazari KT; Gokral J; Pohujani S; Satoskar R
    Clin Pharmacokinet; 1986; 11(2):171-5. PubMed ID: 3956050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered elimination of antipyrine in patients with acute viral hepatitis.
    Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
    Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipyrine clearance during occupational exposure to styrene.
    Døssing M
    Br J Ind Med; 1983 May; 40(2):224-8. PubMed ID: 6131688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determination of antipyrine in human blood and saliva using high performance liquid chromatography].
    Ulc I; Hapala J; Cepeláková H
    Cesk Farm; 1986 Feb; 35(1):22-4. PubMed ID: 3955673
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of menstrual cycle on antipyrine pharmacokinetics in healthy Indian female volunteers.
    Nayak VK; Kshirsagar NA; Desai NK; Satoskar RS
    Br J Clin Pharmacol; 1988 Nov; 26(5):604-6. PubMed ID: 3207565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of antipyrine clearance in humans by propranolol.
    Greenblatt DJ; Franke K; Huffman DH
    Circulation; 1978 Jun; 57(6):1161-64. PubMed ID: 639239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.